Search

everythinglearnresearchcommunity

for

Search:↓

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Substances from dental stem cells might help treat hair loss.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Blue light might help treat skin conditions by affecting the skin's bacteria.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Disease-specific tools better assess alopecia areata's impact on quality of life.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Hair-loss trials have increased, but need more diverse participants and standardized measures.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Caregivers of chronic skin disease patients face significant burdens that harm their quality of life.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Scalp hair loss significantly worsens life quality for many children, especially as they age.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.